Mission Statement, Vision, & Core Values of Legend Biotech Corporation (LEGN)

In the dynamic world of biotechnology, what drives a company pushing the boundaries of medical innovation? For Legend Biotech, a global leader in cell therapy, the answer lies in its clearly defined mission, vision, and core values. With a strong focus on developing groundbreaking therapies, Legend Biotech reported a total revenue of $627.24 million in 2024, marking an impressive 119.97% growth. But what exactly are the guiding principles behind this success, and how do they translate into tangible results for patients and stakeholders alike?

How do these elements shape their strategic decisions and daily operations? And, ultimately, how do they contribute to the company's goal of transforming the landscape of cancer treatment and beyond? Read on to explore the foundational pillars that support Legend Biotech's pursuit of a healthier future.

Legend Biotech Corporation (LEGN) An Overview of

Legend Biotech Corporation (LEGN) is a global biotechnology company dedicated to discovering, developing, manufacturing, and commercializing novel cell therapies for oncology and other indications. Founded with a vision to revolutionize cancer treatment, Legend Biotech has rapidly emerged as a leader in the field of cell therapy, particularly in the development of CAR-T cell therapies. As of April 2025, the company continues to advance its pipeline of innovative therapies, aiming to address unmet medical needs and improve patient outcomes worldwide.

Legend Biotech focuses on developing therapies for hematologic malignancies and solid tumors. The company's primary focus is on CAR-T cell therapy, a type of immunotherapy that uses genetically engineered T cells to target and destroy cancer cells. One of Legend Biotech's notable achievements is the development and commercialization of CARVYKTI® (ciltacabtagene autoleucel), a CAR-T cell therapy approved for the treatment of adult patients with relapsed or refractory multiple myeloma. This therapy has demonstrated high efficacy and has become an important treatment option for patients with this challenging disease.

In the latest financial reports, Legend Biotech has demonstrated strong financial performance, driven primarily by the commercial success of CARVYKTI®. The company reported record-breaking revenue, with significant growth in sales in the United States, Europe, and Japan. For example, in the fourth quarter of 2024, Legend Biotech reported total revenues of $263.2 million, of which $226.5 million was from CARVYKTI® sales. This represents a substantial increase compared to the previous year, highlighting the increasing adoption and market penetration of the therapy.

Legend Biotech's growth is also reflected in its strategic collaborations and expansions. The company has established partnerships with leading pharmaceutical companies to accelerate the development and commercialization of its therapies. These collaborations have provided Legend Biotech with additional resources and expertise, enabling it to expand its research and development efforts and reach more patients globally. Furthermore, Legend Biotech continues to invest in expanding its manufacturing capacity to meet the growing demand for CARVYKTI® and other pipeline products.

Legend Biotech stands as a leader in the biotechnology industry, particularly in the field of cell therapy. Its innovative CAR-T cell therapies, strong financial performance, and strategic collaborations have positioned the company for continued growth and success. To understand the financial health of the company better, consider exploring this resource: Breaking Down Legend Biotech Corporation (LEGN) Financial Health: Key Insights for Investors

Legend Biotech Corporation (LEGN) Mission Statement

Legend Biotech is dedicated to transforming lives through innovative cell therapies. The company's mission is centered around developing, manufacturing, and commercializing groundbreaking treatments for diseases that were once considered untreatable, including various types of cancer. Legend Biotech aims to make a significant impact on patients' lives by providing hope and improving outcomes through its cutting-edge research and development efforts.

Legend Biotech was founded in 2014 and has quickly grown into a global, commercial-stage biotechnology company. The company's initial focus was on advancing antibody-based therapeutics, driven by a team of pioneering scientists with expertise in immunology and gene editing. This foundation has enabled Legend Biotech to emerge as a leader in cell therapy, particularly in the field of oncology.

Here's a closer look at the core components of Legend Biotech's mission:

• Revolutionizing Oncology Treatment: Legend Biotech is committed to revolutionizing the field of oncology by developing and commercializing novel cell therapies. These therapies harness the power of the immune system to target and destroy cancer cells, offering new treatment options for patients in need.
• Advancing Research and Innovation: The company places a strong emphasis on cutting-edge research and innovation. Its dedicated team of scientists and researchers work tirelessly to discover and develop groundbreaking therapies that can improve patient outcomes and enhance their quality of life.
• Global Impact: Legend Biotech aims to extend and improve patients' lives worldwide. The company is dedicated to delivering transformative innovations and ensuring patient access to its therapies.

Legend Biotech's mission is further supported by its vision to be a global leader in cell and gene therapy. The company aspires to create a future where cancers and intractable diseases are curable. This vision drives its commitment to innovation, science, and quality, with the goal of making a meaningful difference in the lives of patients.

As of 2024, Legend Biotech has invested over $1 billion in Research and Development (R&D) since its inception. This substantial investment, along with ongoing collaborations with leading academic institutions, major hospitals, and industry leaders, underscores the company's commitment to cutting-edge and ethical R&D practices.

Legend Biotech's dedication to its mission is evident in its various initiatives, including:

• Engaging with patient advocacy organizations to prioritize patient access and well-being.
• Investing in commercial presence and production capacity to ensure a strong supply chain.
• Utilizing a comprehensive patient support program to assist patients throughout their treatment journey.

The company's commitment extends beyond its scientific endeavors. Legend Biotech fosters a workplace where diverse backgrounds and ideas drive innovation. According to its most recent annual employee engagement survey, 85% of employees feel their work is meaningful, highlighting the company's success in cultivating a workplace where employees are passionate about making a difference.

Legend Biotech's mission is a driving force behind its efforts to develop innovative cell therapy treatments and improve the lives of patients battling cancer and other life-threatening diseases. The company's commitment to research, innovation, and patient care positions it as a key player in the biotechnology industry, working towards a future where more diseases are curable.

More information about Legend Biotech can be found here: Legend Biotech Corporation (LEGN): History, Ownership, Mission, How It Works & Makes Money

Legend Biotech Corporation (LEGN) Vision Statement

A vision statement outlines a company's aspirations for the future. While I don't have access to Legend Biotech's official vision statement as of today, April 16, 2025, I can provide insights into their goals and direction based on their publicly stated objectives and activities.

Focus on Innovation and Development of Novel Therapies

Legend Biotech's core focus revolves around the discovery and development of innovative cell therapies, particularly in the field of oncology. Their primary goal is to create cutting-edge treatments for cancers with high unmet medical needs. This includes:

• Developing novel chimeric antigen receptor (CAR) T-cell therapies.
• Expanding their pipeline to address a broader range of hematologic malignancies and solid tumors.
• Investing in research and development to improve the efficacy and safety of their therapies.

This dedication to innovation is evident in their ongoing clinical trials and research programs. For example, in 2024, Legend Biotech invested $472.2 million in research and development, demonstrating a commitment to advancing their pipeline of novel therapies.

Global Expansion and Commercialization

Legend Biotech aims to establish a global presence and successfully commercialize its therapies to reach patients worldwide. This involves:

• Expanding manufacturing capabilities to meet the growing demand for their products.
• Establishing strategic partnerships to accelerate commercialization in key markets.
• Building a robust commercial infrastructure to support the launch and distribution of their therapies.

In fiscal year 2024, Legend Biotech reported $592.7 million in total revenue, primarily driven by sales of its CAR-T cell therapy. This demonstrates their progress in commercializing innovative therapies and expanding their global reach.

Improving Patient Outcomes

Ultimately, Legend Biotech's vision is centered on improving outcomes for patients with cancer. This encompasses:

• Developing therapies that offer durable remissions and improved quality of life.
• Addressing the challenges of treatment resistance and relapse.
• Collaborating with healthcare professionals and patient advocacy groups to ensure access to their therapies.

Legend Biotech's commitment to patient outcomes is reflected in the clinical data generated from their trials. For instance, studies have shown high overall response rates and durable remissions in patients treated with their lead CAR-T cell therapy. For detailed insights into the financial health of Legend Biotech, you might find this resource helpful: Breaking Down Legend Biotech Corporation (LEGN) Financial Health: Key Insights for Investors

Commitment to Core Values

While their explicit vision statement is not available, Legend Biotech emphasizes values like:

• Integrity
• Innovation
• Collaboration
• Patient-centricity

These values likely underpin their broader vision, guiding their actions and decisions as they pursue their goals. These values are crucial for driving their mission forward and ensuring long-term success.

Legend Biotech Corporation (LEGN) Core Values

A deeper look into the financial standing of Legend Biotech can be found here: Breaking Down Legend Biotech Corporation (LEGN) Financial Health: Key Insights for Investors

Commitment to Innovation

Legend Biotech's primary focus is on the discovery and development of novel cell therapies, particularly in the field of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This commitment is reflected in their ongoing research and development efforts, collaborations with leading research institutions, and investment in cutting-edge technologies.

For example, their collaboration with Janssen Biotech to develop and commercialize CARVYKTI® (ciltacabtagene) demonstrates a dedication to bringing innovative treatments to patients with multiple myeloma. CARVYKTI® received approval from the U.S. Food and Drug Administration (FDA) in 2022 for the treatment of adults with relapsed or refractory multiple myeloma, showcasing their ability to translate research into tangible medical advancements.

Patient-Centric Approach

The development of therapies for life-threatening diseases like multiple myeloma indicates a strong patient-centric approach. This value is demonstrated through their focus on developing effective and safe treatments that improve patient outcomes and quality of life.

Evidence of this patient-centric approach can be seen in their clinical trials, which prioritize patient safety and efficacy. The company also likely engages with patient advocacy groups to understand the needs of patients and incorporate their feedback into the development process.

Integrity and Transparency

As a publicly traded company, Legend Biotech is committed to maintaining high standards of integrity and transparency in its operations. This includes adhering to regulatory requirements, disclosing financial information accurately, and communicating openly with stakeholders.

For instance, Legend Biotech's filings with the U.S. Securities and Exchange Commission (SEC) provide detailed information about its financial performance, business operations, and risk factors. This transparency allows investors and other stakeholders to make informed decisions about the company.

Collaboration and Partnership

Legend Biotech recognizes the importance of collaboration and partnership in achieving its goals. This is evident in their strategic alliances with other companies, research institutions, and healthcare providers.

Their partnership with Janssen Biotech for CARVYKTI® is a prime example of this value. By combining their expertise and resources, Legend Biotech and Janssen were able to accelerate the development and commercialization of this important therapy for multiple myeloma.

Focus on Quality and Safety

Given that Legend Biotech operates in the biopharmaceutical industry, a commitment to quality and safety is paramount. This value is reflected in their rigorous manufacturing processes, quality control procedures, and adherence to regulatory guidelines.

The company likely invests heavily in ensuring that its manufacturing facilities meet the highest standards of quality and safety. They also have robust systems in place to monitor and manage any potential risks associated with their products.